Organ Transplant Flashcards
Indications for a Kidney transplant
- Diabetes
- Hypertension
- Lupus
- PCKD
Indications for a liver transplant
- Alcoholic cirrhosis
- NASH
- HBV
- HCC
- APAP toxicity
Indications for Pancreas transplant
- Diabetes
- Congenital abnormalitites
Indications for Heart transplant
- Ischemic heart disease
- Congenital abnormalities
- Idiopathic cardiomyopathy
- Valvular diseases
Indications for Lung transplant
- CF
- Pulmonary HTN
- Pulmonary fibrosis
- COPD
- Emphysema
Goals of Immunosuppression
- Prevent rejection
- Avoid complications
- Patient and graft survival
- Patient adherence
Phases of Immunosuppression
- Desensitization
- Induction
- Maintenance
Least to most immunogenic organs
- Liver
- Kidneys
- Pancreas
- Heart
- Lungs
- Colon
Induction Therapy Goal
- Prevent early acute graft rejection
- Decrease T cells and/or B cells for months
Drugs that can be used for induction therapy
- Basiliximab
- Antithymocyte globulin
- Alemtuzumab
Basliximab (Simulect) Mechanism of Action
- Blocks T cell proliferation
- Via interleukin 2 (IL-2)
- Anti CD25 antibodies
- Used in lowest immunologic risk patients
Antithymocyte Globulin (Thymoglobulin) Mechanism of Action
- Binds to T cell surface antigens
- leading to depletion of T cells
- Used in moderate to high immunologic risk
- Increased risk of CMV, BKV, and PJP
Alemtuzumab (Campath) Mechanism of action
- Binds to CD52 on T cells, B cells, NK cells, and monocytes/macrophages
- “AIDs” in a bottle
- 1+ year for CD4/8 counts to recover
- Associated with many opportunistic infections
Maintenance Therapy Goal
- Prevent graft rejection
- Life long immunosuppression
Drugs that can be used for Maintenance Therapy
- Corticosteroids
- Calcineurin inhibitors
- Antimetabolites
- mTOR inhibitors
Corticosteroids mechanism of action
- Inhibit cytokine gene expression
- Modify lymphocyte distribution and function
- Anti inflammatory
ex. prednisone 5-10mg/day
Corticosteroid long term side effects
- Osteoporosis
- Adrenal insufficiency
- pancreatitis
- Amenorrhea
- Diabetes mellitius
Corticosteroid short term side effects
-Mood change
-Hyperglycemia
-Hypertension
-Insomnia
-Acne
increased appetite
Tacrolimus (FK506) and Cyclosporine (Calcineurin inhibitors) Mechanism of action
- Inhibit T cell activity through inhibition of IL-2 production
- Has crummy bioavailability and variable half life
Therapeutic range of Tacrolimus (FK506)
-5 to 15ng/mL
Tacrolimus interactions
- Ketoconazole, diltiazem,
- Phenytoin, rifampn
- P glycoprotein substrate
- Antacids
Cyclosporine Therapeutic Range
-50 to 200ng/mL
Cyclosporine drug interactions
- Ketoconazole, diltiazem
- Phenytoin, rifampin
- P glycoprotein
- Food (keep it consistent)
Tacrolimus monitoring
-Trough levels